Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds...
Researchers at Brigham and Women’s Hospital (BWH) and colleagues have demonstrated for the first time in humans in a randomized clinical trial that low-dose aspirin - dosages equivalent to one baby aspirin (81 mg) - trigger the body to generate its own anti-inflammatory compounds that help fight unwanted inflammation.
This finding has implications for heart disease, arthritis and many other diseases, which are now recognized to be associated with inflammation. This research, which is published in the October 2004 issue of the Proceedings of the National Academy of Sciences (PNAS), demonstrates that aspirin, a COX-1 inhibitor, unlike COX-2 inhibitors, also generates "good" anti-inflammatory compounds necessary to fight disease.
http://www.news-medical.net/?id=5579